寡核苷酸
超分子化学
纳米技术
西斯特
核苷酸
材料科学
计算生物学
共价键
DNA
临床诊断
分子探针
生物
分子识别
金标准(测试)
荧光
生物物理学
杂交探针
遗传学
DNA微阵列
多路复用
生物传感器
分子诊断学
组合化学
作者
K M Neethu,Paresh Mohanty,Neelam,Gunjan Verma,Sugam Kumar,Rijo Rajeev,Chiranjit Bose,Chinmay Saha,Sunetra Mondal,Nitai P Bhattacharrya,Satinath Mukhopadhyay,Parikshit Moitra
摘要
ABSTRACT Turner Syndrome (TS), a rare chromosomal disorder, cause significant phenotypical changes like growth failure and primary ovarian insufficiency. Chromosomal karyotyping, the preferred diagnostic method till date, resulting in delayed diagnosis that precludes early intervention. Hence, there is a clear unmet clinical need for rapid and cost‐effective diagnostic tool for TS. The current study focuses on developing a multiplexed molecular sensing platform that couples post‐synthetically modified, emissive COF with gold‐nanostars and gene‐specific oligonucleotides to detect TS‐associated DNA. The sensing mechanism relies on a unique self‐organization of this nucleotide decorated 2D‐COF assemblies and 3D‐gold‐nanostars in presence of their target DNA sequence. This nucleotide‐driven 2D‐3D self‐organization translates molecular recognition into convergent, trimodal readouts, i.e., fluorescence, UV–Vis, and photoacoustic scattering, from a single material construct. Responses from nineteen different rare diseased samples toward the sensor platform are compared against healthy specimens. The developed sensor has been observed to quantitatively distinguish gene‐level signatures spanning SHOX, ARSE, XIST, and VAMP7, achieving limits of detection down to 5.2–61.2 pg/mL and diagnostic accuracy up to >95% for XIST when benchmarked against gold standard methods. This programmable supramolecular assembly might have the potential to become an integral part of newborn screening programs, offering early therapeutic opportunities for TS‐affected individuals.
科研通智能强力驱动
Strongly Powered by AbleSci AI